Literature DB >> 10922968

Structural involvement in type 1 and type 2 diabetic nephropathy.

M Dalla Vestra1, A Saller, E Bortoloso, M Mauer, P Fioretto.   

Abstract

Structural changes underlying diabetic nephropathy in Type 1 diabetes are prodominant in the glomerulus [thickening of glomerular basement membrane (GBM) and mesangial expansion], but also include arteriolar, tubular and interstitial lesions. The structural measure that correlates best with all renal functional parameters in Type 1 diabetes is mesangial fractional volume [Vv(mes/glom)], an estimate of mesangial expansion. Structural-functional relationships in Type 2 diabetes are much less known. These studies investigated renal structure in the early stages of nephropathy [microalbuminuria (MA)] in patients with Type 1 and Type 2 diabetes. Diabetic glomerulopathy was quite advanced in Type 1 diabetic patients with MA, and both Vv (mes/glom) and GBM width were increased as compared to normoalbuminuric (NA) patients when the albumin excretion rate (AER) was > 30 microgram/min. Serial renal biopsies were performed 5 years apart in 11 Type 1 diabetic patients to evaluate whether glomerular and interstitial lesions progress jointly. AER increased significantly in 5 years, while the glomerular filtration rate remained unchanged. All structural parameters were initially abnormal. Vv(mes/glom) and mean glomerular volume increased significantly, whereas GBM width and the interstitial volume fraction were unchanged. Moreover, the change in Vv (mes/glom) was correlated with the change in AER (r =0.64, p <0.05). Thus, at the disease stage during which some patients progress to MA or proteinuria, continuing mesangial expansion is the main variable, whereas further interstitial expansion does not occur. A large number of Type 2 patients were also studied. Early diabetic glomerulopathy was detected by electron microscopy in NA patients and found to be more advanced in those with MA and proteinuria. However, lesions were milder than in Type 1 diabetic patients, and there was considerable overlap between groups. Morphometric results by electron microscopy were similar to those by light microscopy, demonstrating the heterogeneity of renal structure in Type 2 diabetic patients. In fact, only 30% of MA patients had typical diabetic glomerulopathy, while 40% had more advanced tubulo-interstitial and/or vascular lesions and 30% had normal renal structure.

Entities:  

Mesh:

Year:  2000        PMID: 10922968

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  39 in total

1.  Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.

Authors:  C Huang; Y Kim; M L Caramori; A J Fish; S S Rich; M E Miller; G B Russell; M Mauer
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

2.  Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model.

Authors:  Qian Zhang; Xinhua Xiao; Ming Li; Wenhui Li; Miao Yu; Huabing Zhang; Xiaofang Sun; Lili Mao; Hongding Xiang
Journal:  J Nat Med       Date:  2012-03-21       Impact factor: 2.343

3.  A 100-kDa urinary protein is associated with insulin resistance in offspring of type 2 diabetic patients.

Authors:  A Pätäri; P Karhapää; H Taipale; U Salmenniemi; E Ruotsalainen; P Vanninen; H Holthöfer; M Laakso
Journal:  Diabetologia       Date:  2005-07-08       Impact factor: 10.122

Review 4.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

5.  Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study.

Authors:  Behzad Najafian; Awais Masood; Patrick C Malloy; Alfonso Campos; Barbara C Hansen; Michael Mauer; M Luiza Caramori
Journal:  Diabetes Metab Res Rev       Date:  2011-05       Impact factor: 4.876

6.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 7.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 8.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

Review 9.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  The use of lysosomal enzymuria in the early detection and monitoring of the progression of diabetic nephropathy.

Authors:  Donatien Gatsing; Ibrahim Hassan Garba; Godwin I Adoga
Journal:  Indian J Clin Biochem       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.